A detailed history of Black Rock Inc. transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Black Rock Inc. holds 12,062,213 shares of ACAD stock, worth $196 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,062,213
Previous 11,668,740 3.37%
Holding current value
$196 Million
Previous $216 Million 9.15%
% of portfolio
0.0%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$14.62 - $18.42 $5.75 Million - $7.25 Million
393,473 Added 3.37%
12,062,213 $196 Million
Q1 2024

May 10, 2024

BUY
$17.79 - $30.86 $4.59 Million - $7.97 Million
258,257 Added 2.26%
11,668,740 $216 Million
Q4 2023

Feb 13, 2024

BUY
$20.78 - $31.77 $28.7 Million - $43.9 Million
1,381,898 Added 13.78%
11,410,483 $357 Million
Q3 2023

Nov 13, 2023

SELL
$20.84 - $33.47 $227,489 - $365,358
-10,916 Reduced 0.11%
10,028,585 $209 Million
Q2 2023

Aug 11, 2023

BUY
$17.8 - $25.65 $3.03 Million - $4.37 Million
170,370 Added 1.73%
10,039,501 $240 Million
Q1 2023

May 12, 2023

SELL
$16.32 - $20.92 $6.37 Million - $8.16 Million
-390,053 Reduced 3.8%
9,869,131 $186 Million
Q4 2022

Feb 13, 2023

BUY
$14.2 - $18.63 $4.06 Million - $5.33 Million
286,029 Added 2.87%
10,259,184 $163 Million
Q3 2022

Nov 14, 2022

BUY
$14.11 - $18.27 $3.27 Million - $4.24 Million
231,841 Added 2.38%
9,973,155 $163 Million
Q2 2022

Aug 12, 2022

SELL
$13.01 - $27.22 $2.98 Million - $6.23 Million
-228,709 Reduced 2.29%
9,741,314 $137 Million
Q1 2022

May 12, 2022

SELL
$20.94 - $27.5 $1.89 Million - $2.48 Million
-90,289 Reduced 0.9%
9,970,023 $241 Million
Q4 2021

Feb 10, 2022

SELL
$16.79 - $27.09 $1.59 Million - $2.56 Million
-94,639 Reduced 0.93%
10,060,312 $235 Million
Q3 2021

Nov 09, 2021

BUY
$15.78 - $24.77 $248,503 - $390,077
15,748 Added 0.16%
10,154,951 $169 Million
Q2 2021

Aug 11, 2021

BUY
$19.4 - $27.42 $197 Million - $278 Million
10,139,203 New
10,139,203 $247 Million

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.63B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.